| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| OREBRITON 90 mg | TICAGRELOR | COMPR. FILM. | B01AC24 | W68937005 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON 90 mg | TICAGRELOR | COMPR. FILM. | B01AC24 | W68937006 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON 90 mg | TICAGRELOR | COMPR. FILM. | B01AC24 | W68937007 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON 90 mg | TICAGRELOR | COMPR. FILM. | B01AC24 | W68937008 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON DUO 90 mg/50 mg | COMBINATII (CLOPIDOGRELUM+ACIDUM ACETYLSALICYLICUM) | CAPS. | B01AC30 | W71936001 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON DUO 90 mg/50 mg | COMBINATII (CLOPIDOGRELUM+ACIDUM ACETYLSALICYLICUM) | CAPS. | B01AC30 | W71936002 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON DUO 90 mg/50 mg | COMBINATII (CLOPIDOGRELUM+ACIDUM ACETYLSALICYLICUM) | CAPS. | B01AC30 | W71936003 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON DUO 90 mg/50 mg | COMBINATII (CLOPIDOGRELUM+ACIDUM ACETYLSALICYLICUM) | CAPS. | B01AC30 | W71936004 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON DUO 90 mg/50 mg | COMBINATII (CLOPIDOGRELUM+ACIDUM ACETYLSALICYLICUM) | CAPS. | B01AC30 | W71936005 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON DUO 90 mg/50 mg | COMBINATII (CLOPIDOGRELUM+ACIDUM ACETYLSALICYLICUM) | CAPS. | B01AC30 | W71936006 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| OREBRITON DUO 90 mg/50 mg | COMBINATII (CLOPIDOGRELUM+ACIDUM ACETYLSALICYLICUM) | CAPS. | B01AC30 | W71936007 | ZENTIVA, K.S. - REPUBLICA CEHA | ||||||
| ORENCIA 125 mg/ml | ABATACEPTUM | SOL. INJ. IN SERINGA PREUMPLUTA | L04AA24 | W65571005 | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | X | |||||
| ORENCIA 250 mg | ABATACEPTUM | PULB. PT. CONC. PT. SOL. PERF. | L04AA24 | W65570001 | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | X | |||||
| ORENCIA 250 mg | ABATACEPTUM | PULB. PT. CONC. PT. SOL. PERF. | L04AA24 | W65570002 | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | X | |||||
| ORENCIA 250 mg | ABATACEPTUM | PULB. PT. CONC. PT. SOL. PERF. | L04AA24 | W65570003 | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | X | |||||
| ORFADIN 10mg | NITISINONUM | CAPS. | A16AX04 | W51629001 | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB - SUEDIA | X | |||||
| ORFADIN 2mg | NITISINONUM | CAPS. | A16AX04 | W51622001 | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB - SUEDIA | X | |||||
| ORFADIN 5mg | NITISINONUM | CAPS. | A16AX04 | W51627001 | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB - SUEDIA | X | |||||
| ORFIRIL LONG 1000 mg | ACIDUM VALPROICUM + SARURI | MINICOMPR. ELIB. PREL. | N03AG01 | W08325004 | DESITIN ARZNEIMITTEL GMBH - GERMANIA | ||||||
| ORFIRIL LONG 1000 mg | ACIDUM VALPROICUM + SARURI | MINICOMPR. ELIB. PREL. | N03AG01 | W08325002 | DESITIN ARZNEIMITTEL GMBH - GERMANIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman